| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.5% | 76.5% | 74.88% | 74.87% | 74.87% | 72.71% | 72.7% | 72.68% | 72.67% | 72.66% | 72.66% | 72.63% | |
| 4.18% | 6.74% | 9.87% | 11.58% | 12.37% | 13.34% | 12.92% | 13.07% | 12.84% | 11.34% | 10.24% | 9.45% | |
| 4.56% | 9.79% | 11.14% | 9.95% | 9.9% | 11.06% | 11.48% | 11.5% | 11.92% | 13.25% | 14.46% | 15.39% | |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 14.76% | 6.97% | 4.11% | 3.6% | 2.86% | 2.89% | 2.9% | 2.75% | 2.57% | 2.75% | 2.64% | 2.53% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 1,70,347 | 1,77,539 | 1,77,606 | 1,66,715 |
Promoter holding down 3.87 percentage points since Sep 2023.
103 deals · 20 Oct 2023 – 14 Oct 2025
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 14 Oct 2025 | GOLDMAN SACHS BANK EUROPE SE - ODI | Block | NSE | Buy | 55,000 | ₹2,430.00 | ₹13.37 Cr |
| 14 Oct 2025 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | Block | NSE | Sell | 55,000 | ₹2,430.00 | ₹13.37 Cr |
| 13 Oct 2025 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | Block | NSE | Sell | 42,245 | ₹2,440.00 | ₹10.31 Cr |
| 13 Oct 2025 | GOLDMAN SACHS BANK EUROPE SE - ODI | Block | NSE | Buy | 42,245 | ₹2,440.00 | ₹10.31 Cr |
| 9 May 2025 | GOLDMAN SACHS (SINGAPORE) PTE.- ODI | Block | BSE | Buy | 55,000 | ₹2,434.10 | ₹13.39 Cr |
| 9 May 2025 | COPTHALL MAURITIUS INVESTMENT LIMITED | Block | BSE | Sell | 55,000 | ₹2,434.10 | ₹13.39 Cr |
| 5 Feb 2025 | ORBIMED GENESIS MASTER FUND L.P. | Block | NSE | Buy | 45,000 | ₹2,555.10 | ₹11.50 Cr |
| 5 Feb 2025 | COPTHALL MAURITIUS INVESTMENT LIMITED | Block | NSE | Sell | 45,000 | ₹2,555.10 | ₹11.50 Cr |
| 10 Jul 2024 | HEMA CIPEF (I) LIMITED | Block | NSE | Sell | 18,50,850 | ₹2,082.00 | ₹385.35 Cr |
| 10 Jul 2024 | ICICI PRUDENTIAL MUTUAL FUND A/C ICICI PRUDENTIAL INDIA OPPORTUNITIES FUND | Block | NSE | Buy | 4,37,238 | ₹2,082.00 | ₹91.03 Cr |
1–10 of 103
1 / 11
- Mr. Ramesh JunejaExecutive Director-Chairperson related to Promoter
- Mr. Rajeev JunejaExecutive Director-MD
- Mr. Sheetal AroraExecutive Director-CEO
- Mr. Satish Kumar SharmaExecutive Director
- Mr. Tilokchand Punamchand OstwalNon-Executive - Independent Director
- Mr. Bharat AnandNon-Executive - Independent Director
- Mrs. Vijaya SampathNon-Executive - Independent Director
- Mr. Vivek Santokh KalraNon-Executive - Independent Director
- Mr. Ashutosh DhawanChief Financial Officer
- Mr. Hitesh Kumar JainCompany Secretary & Compliance Officer
Current officeholders as filed with BSE. A person holding two offices is listed once per office.